Direct-to-Consumer Alzheimer s Blood Test Opens Pandora s Box
alzforum.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alzforum.org Daily Mail and Mail on Sunday newspapers.
Spying on α-Synuclein Inclusions: PET Tracers Inch Closer to Success
alzforum.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alzforum.org Daily Mail and Mail on Sunday newspapers.
Is a Waning Locus Coeruleus an Early Sign of Alzheimer s Disease?
alzforum.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alzforum.org Daily Mail and Mail on Sunday newspapers.
24 Apr 2021
With disease-modifying treatments for Alzheimer’s disease potentially on the cusp of approval, there will be pressing demand for quick, simple ways to screen patients and determine if they have amyloid plaque in their brains. The current gold-standard diagnostics used in research amyloid PET scans and cerebrospinal fluid biomarkers are expensive, invasive, or not readily available to many patients. With that in mind, the Global Alzheimer’s Platform has launched Bio-Hermes, a collaborative study with 10 different technology companies that will assess how accurately low-cost, rapid blood-based, and digital biomarker tests detect amyloid accumulation and cognitive decline.
Bio-Hermes study will assess digital and blood-based biomarkers.